Real-time enrollment status for this schizophrenia clinical trial
Current Status
Recruiting
Checked: July 28, 2026 at 5:07 PM UTC
| NCT Number | NCT07369154 |
| Recruiting Status | Recruiting |
| Condition | Schizophrenia |
| Phase | PHASE3 |
| Target Enrollment | 900 participants |
| Active Locations | 23 sites in the US |
| Sponsor | LB Pharmaceuticals Inc. |
| Last Updated on CT.gov | July 27, 2026 (Yesterday) |
As of July 28, 2026: Clinical trial NCT07369154 is currently recruiting participants. This phase3 study for schizophrenia is actively seeking new participants at 23 locations across the United States. The study is sponsored by LB Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07369154 is actively recruiting participants as of July 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 23 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07369154 was last updated Yesterday (July 27, 2026). HelloStudys verifies this status automatically.